Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
KP Tissue ( (TSE:KPT) ) has issued an announcement.
KP Tissue Inc. reported a 7.7% increase in revenue for Q3 2025, reaching $561.1 million, driven by higher sales volumes and favorable pricing. The company also announced plans to build a new TAD tissue facility by 2028 to support its growth in ultra-premium products, reflecting its strategic focus on expanding market share and enhancing operational capacity.
The most recent analyst rating on (TSE:KPT) stock is a Hold with a C$10.00 price target. To see the full list of analyst forecasts on KP Tissue stock, see the TSE:KPT Stock Forecast page.
Spark’s Take on TSE:KPT Stock
According to Spark, TipRanks’ AI Analyst, TSE:KPT is a Neutral.
KP Tissue’s overall stock score reflects a mix of strengths and challenges. The strong balance sheet and positive earnings call outlook are significant positives, enhancing stability and growth potential. However, profitability issues, high P/E ratio, and mixed technical indicators present cautionary elements. The attractive dividend yield provides some valuation support, but overall, the stock’s performance hinges on continued operational improvements and strategic execution amid external challenges.
To see Spark’s full report on TSE:KPT stock, click here.
More about KP Tissue
Kruger Products Inc., a leading Canadian manufacturer, specializes in quality tissue products for both the Consumer and Away-From-Home markets. The company is expanding its presence in the U.S. Consumer tissue business with brands like White Cloud® and premium private label products.
Average Trading Volume: 17,076
Technical Sentiment Signal: Buy
Current Market Cap: C$94.28M
For an in-depth examination of KPT stock, go to TipRanks’ Overview page.